16 Results for "

Acat 1 Inhibitors

" in MedChemExpress (MCE) Product Catalog:
Products (16)

16 Results for "Acat 1 Inhibitors" in MCE Product Catalog:

20
20 Publications Verification
Cat. No.: HY-13215
CAS No.: 166518-60-1
Purity:  99.77%
Synonyms: CI-1011; PD-148515
Target:  

Acyltransferase

Research Areas:  

Cancer

Avasimibe (CI-1011; PD-148515) is an orally active acyl coenzyme A-cholesterol acyltransferase (ACAT; also called SOAT)) inhibitor with IC50s of 24 and 9.2 µM for ACAT1 and ACAT2, respectively . Avasimibe can be used for the research of prostate cancer .
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-100400A
CAS No.: 217094-32-1
Purity:  99.42%
Target:  

Acyltransferase

Research Areas:  

Cardiovascular Disease

K-604 dihydrochloride is a potent and selective acyl-CoA:cholesterol acyltransferase 1 (ACAT-1) inhibitor with an IC50 of 0.45±0.06 μM.
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-100399
CAS No.: 133825-80-6
Synonyms: PD-132301; ATR-101
Research Areas:  

Cancer

Nevanimibe (PD-132301) is an orally active and selective acyl-coenzyme A:cholesterol O-acyltransferase 1 (ACAT1) inhibitor with an EC50 of 9 nM. Nevanimibe inhibits ACAT2 with an EC50 of 368 nM. Nevanimibe induces cell apoptosis and has the potential for adrenocortical cancer .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-100399A
CAS No.: 133825-81-7
Purity:  99.49%
Synonyms: PD-132301 hydrochloride; ATR101 hydrochloride
Research Areas:  

Cancer

Nevanimibe hydrochloride (PD-132301 hydrochloride) is an orally active and selective acyl-coenzyme A:cholesterol O-acyltransferase 1 (ACAT1) inhibitor with an EC50 of 9 nM. Nevanimibe hydrochloride inhibits ACAT2 with an EC50 of 368 nM. Nevanimibe hydrochloride induces cell apoptosis and has the potential for adrenocortical cancer .
loading...
    loading...
Cat. No.: HY-111880
CAS No.: 78886-65-4
Purity:  99.23%
γ-Sanshool can be isolated from Zanthoxylum piperitum. γ-Sanshool inhibits human ACAT-1 and ACAT-2 activities with IC50s of 12.0 and 82.6 μM .
loading...
    loading...
Cat. No.: HY-100401
CAS No.: 189198-30-9
Purity:  99.98%
Synonyms: CS-505 free base
Target:  

Acyltransferase

Research Areas:  

Cardiovascular Disease

Pactimibe (CS-505 free base) is a dual ACAT1/2 inhibitor with IC50s of 4.9 μM and 3.0 μM, respectively. Pactimibe (CS-505 free base) inhibits ACAT with IC50s of 2.0 μM, 2.7 μM, 4.7 μM in the liver, macrophages and THP-1 cells, respectively . Pactimibe (CS-505 free base) noncompetitively inhibits oleoyl-CoA with a Ki value of 5.6 μM. Moreover, Pactimibe (CS-505 free base) obviously inhibits cholesteryl ester formation with an IC50 of 6.7 μM. Pactimibe (CS-505 free base) possesses anti-atherosclerotic potential with lowering plasma cholesterol activity .
loading...
    loading...
Cat. No.: HY-100401A
CAS No.: 608510-47-0
Purity:  ≥98.0%
Synonyms: CS-505
Target:  

Acyltransferase

Research Areas:  

Cardiovascular Disease

Pactimibe sulfate (CS-505) is a dual ACAT1/2 inhibitor with IC50s of 4.9 μM and 3.0 μM, respectively. Pactimibe sulfate (CS-505) inhibits ACAT with IC50s of 2.0 μM, 2.7 μM, 4.7 μM in the liver, macrophages and THP-1 cells, respectively . Pactimibe sulfate (CS-505) noncompetitively inhibits oleoyl-CoA with a Ki value of 5.6 μM. Moreover, Pactimibe sulfate (CS-505) obviously inhibits cholesteryl ester formation with an IC50 of 6.7 μM. Pactimibe sulfate (CS-505) possesses anti-atherosclerotic potential with lowering plasma cholesterol activity .
loading...
    loading...
Cat. No.: HY-120082
CAS No.: 179054-51-4
Target:  

Acyltransferase

Research Areas:  

Metabolic Disease

FR-182980 is an orally active ACAT1 inhibitor (IC50: 30 nM). FR-182980 has hypocholesterolemic activity and can be used for research of atherosclerosis .
loading...
    loading...
Cat. No.: HY-100400AR
CAS No.: 217094-32-1
K-604 (dihydrochloride) (Standard) is the analytical standard of K-604 (dihydrochloride). This product is intended for research and analytical applications. K-604 dihydrochloride is a potent and selective acyl-CoA:cholesterol acyltransferase 1 (ACAT-1) inhibitor with an IC50 of 0.45±0.06 μM.
loading...
    loading...
Cat. No.: HY-13215R
CAS No.: 166518-60-1
Synonyms: CI-1011 (Standard); PD-148515 (Standard)
Research Areas:  

Cancer

Avasimibe (Standard) is the analytical standard of Avasimibe. This product is intended for research and analytical applications. Avasimibe (CI-1011; PD-148515) is an orally active acyl coenzyme A-cholesterol acyltransferase (ACAT; also called SOAT)) inhibitor with IC50s of 24 and 9.2 µM for ACAT1 and ACAT2, respectively . Avasimibe can be used for the research of prostate cancer .
loading...
    loading...
Cat. No.: HY-100399AR
CAS No.: 133825-81-7
Synonyms: PD-132301 hydrochloride (Standard); ATR101 hydrochloride (Standard)
Research Areas:  

Cancer

Nevanimibe hydrochloride (Standard) is the analytical standard of Nevanimibe hydrochloride. This product is intended for research and analytical applications. Nevanimibe hydrochloride (PD-132301 hydrochloride) is an orally active and selective acyl-coenzyme A:cholesterol O-acyltransferase 1 (ACAT1) inhibitor with an EC50 of 9 nM. Nevanimibe hydrochloride inhibits ACAT2 with an EC50 of 368 nM. Nevanimibe hydrochloride induces cell apoptosis and has the potential for adrenocortical cancer .
loading...
    loading...
Cat. No.: HY-N14968
CAS No.: 144446-20-8
Enniatin F has insecticidal and antifungal activity. Enniatin F also can inhibit acyl-CoA, cholesterol acyltransferase (ACAT) .
loading...
    loading...
Cat. No.: HY-118486
CAS No.: 615264-52-3
Purity:  ≥99.0%
Target:  

Acyltransferase

Research Areas:  

Metabolic Disease

LDL-IN-1 (Compound 1) is an antioxidant, and is active against copper mediated LDL oxidation (IC50 = 52 μM). LDL-IN-1 is also an Acyl-CoA:cholesterol acyltransferase-1 and -2 (ACAT-1/2) inhibitor, with IC50s of 60 μM. LDL-IN-1 can be used for anti-atherosclerotic research .
loading...
    loading...
Cat. No.: HY-13215A
CAS No.: 166518-61-2
Synonyms: CI-1011 sodium; PD-148515 sodium
Target:  

Acyltransferase

Research Areas:  

Cancer

Avasimibe sodium (CI-1011 sodium; PD-148515 sodium) is an orally active acyl coenzyme A-cholesterol acyltransferase (ACAT; also called SOAT)) inhibitor with IC50s of 24 and 9.2 µM for ACAT1 and ACAT2, respectively . Avasimibe sodium can be used for the research of prostate cancer .
loading...
    loading...
Cat. No.: HY-N18066
CAS No.: 854381-37-6
Esculeogenin A is the sapogenol of tomato saponin Esculeoside A (HY-N18067). Esculeogenin A is an orally active hepatoprotective, hypolipidemic, and antioxidant agent. Esculeogenin A regulates molecular targets like PPARα, SREBP1, Nrf2, NF-κB, ACAT1/ACAT2 to promote hepatic fatty acid oxidation, suppress de novo lipogenesis, enhance antioxidant defense, and inhibit inflammation. Esculeogenin A improves liver function, alleviates hyperlipidemia, and inhibits hepatic steatosis and foam cell formation, preventing nonalcoholic fatty liver disease in high-fat-diet-fed rats and reducing atherosclerotic lesions in apoE-deficient mice. Esculeogenin A can be used for the research of nonalcoholic fatty liver disease, atherosclerosis, and hyperlipidemia .
loading...
    loading...
Cat. No.: HY-100401AR
CAS No.: 608510-47-0
Synonyms: CS-505 (Standard)
Pactimibe (sulfate) (Standard) is the analytical standard of Pactimibe (sulfate) (HY-100401A). This product is intended for research and analytical applications. Pactimibe sulfate (CS-505) is a dual ACAT1/2 inhibitor with IC50s of 4.9 μM and 3.0 μM, respectively. Pactimibe sulfate (CS-505) inhibits ACAT with IC50s of 2.0 μM, 2.7 μM, 4.7 μM in the liver, macrophages and THP-1 cells, respectively . Pactimibe sulfate (CS-505) noncompetitively inhibits oleoyl-CoA with a Ki value of 5.6 μM. Moreover, Pactimibe sulfate (CS-505) obviously inhibits cholesteryl ester formation with an IC50 of 6.7 μM. Pactimibe sulfate (CS-505) possesses anti-atherosclerotic potential with lowering plasma cholesterol activity .
loading...
    loading...
  • 1